The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly involved in the various aspects of diagnosis. On the occasion of the annual ELN meeting of 2015 in Mannheim, these four work packages collectively examined the current situation and future prospects of cytomorphology, flow cytometry, cytogenetics, next-generation sequencing, and minimal residual disease detection in the context of leukemia diagnosis and follow-up. This document summarizes the outcome of this compendium
The increasing knowledge of molecular genetics of acute myeloid leukemia (AML) urged the update of p...
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and manag...
Acute leukaemia is a neoplastic disorder of haematopoietic precursors characterized by a rapid clini...
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly inv...
The European LeukemiaNet (ELN), workpackage 10 (WP10) was designed to deal with diagnosis matters us...
The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemi...
Acute leukaemia is a neoplastic disorder of haematopoietic precursors characterized by a rapid clini...
Laboratory diagnosis for acute leukemia classification is necessary for both treatment and prognosis...
Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal prolife...
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of ...
At present, hemato-oncologic diagnostics is facing dynamic changes. This applies to the exploration ...
The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in ...
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML...
The increasing knowledge of molecular genetics of acute myeloid leukemia (AML) urged the update of p...
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and manag...
Acute leukaemia is a neoplastic disorder of haematopoietic precursors characterized by a rapid clini...
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly inv...
The European LeukemiaNet (ELN), workpackage 10 (WP10) was designed to deal with diagnosis matters us...
The only way to cure leukemia is by cooperative research. To optimize research, the European Leukemi...
Acute leukaemia is a neoplastic disorder of haematopoietic precursors characterized by a rapid clini...
Laboratory diagnosis for acute leukemia classification is necessary for both treatment and prognosis...
Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal prolife...
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of ...
At present, hemato-oncologic diagnostics is facing dynamic changes. This applies to the exploration ...
The impact of cytogenetic characterization based on chromosome banding analyses and fluorescence in ...
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML...
The increasing knowledge of molecular genetics of acute myeloid leukemia (AML) urged the update of p...
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and manag...
Acute leukaemia is a neoplastic disorder of haematopoietic precursors characterized by a rapid clini...